KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Current Taxes (2016 - 2025)

Historic Current Taxes for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $469.0 million.

  • Abbott Laboratories' Current Taxes fell 3422.16% to $469.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $469.0 million, marking a year-over-year decrease of 3422.16%. This contributed to the annual value of $594.0 million for FY2024, which is 2073.17% up from last year.
  • Abbott Laboratories' Current Taxes amounted to $469.0 million in Q3 2025, which was down 3422.16% from $390.0 million recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' Current Taxes ranged from a high of $713.0 million in Q3 2024 and a low of $242.0 million during Q2 2021
  • Over the past 5 years, Abbott Laboratories' median Current Taxes value was $368.0 million (recorded in 2021), while the average stood at $413.3 million.
  • As far as peak fluctuations go, Abbott Laboratories' Current Taxes skyrocketed by 21452.99% in 2021, and later crashed by 3510.82% in 2025.
  • Abbott Laboratories' Current Taxes (Quarter) stood at $306.0 million in 2021, then increased by 12.09% to $343.0 million in 2022, then soared by 43.44% to $492.0 million in 2023, then grew by 20.73% to $594.0 million in 2024, then dropped by 21.04% to $469.0 million in 2025.
  • Its last three reported values are $469.0 million in Q3 2025, $390.0 million for Q2 2025, and $485.0 million during Q1 2025.